🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this open-label extension trial was to evaluate th...
Status
Terminated
Location
Clinical Research Site
Start Date
2024-11-21
Trial ID
NCT06736509
Treatments Being Tested
This study is an open-label drug-drug interaction (DDI) study of ZYN002 tra...
Status
Completed
Location
CMAX Clinical Research
Start Date
2025-06-06
Trial ID
NCT06930872
This trial was a multi-center, double-blind, placebo-controlled, randomized...
Status
Completed
Location
Clinical Research Site
Start Date
2022-09-06
Trial ID
NCT05557409
A Phase I, Open-label, Fixed-sequence, Crossover, Drug-drug Interaction Stu...
Status
Completed
Location
Volunteer recruitment center Covance Leeds Covance Leeds
Start Date
2020-11-10
Trial ID
NCT04643249
Treatments Being Tested
A Phase 3, randomized, double-blind, placebo-controlled, multicenter trial ...
Status
Completed
Location
Clinical Research Site
Start Date
2019-06-20
Trial ID
NCT04019704
This is a single center, open-label, fixed sequence Phase 1, drug-drug inte...
Status
Completed
Location
ICON Early Phase Services
Start Date
2022-04-26
Trial ID
NCT05334108
We propose here to explore systematically the association between drug-meta...
Status
Unknown
Location
Hôpitaux Universitaires de Genève
Start Date
2014-12
Trial ID
NCT02438072
Treatments Being Tested
Phenotyping is an approach largely used for the evaluation of the activity ...
Status
Completed
Location
University Hospitals
Start Date
2012-11
Trial ID
NCT01731067
Treatments Being Tested
An open-label, long-term, safety study of AXS-05 in patients with major dep...
Status
Completed
Location
Clinical Research Site
Start Date
2019-07-08
Trial ID
NCT04039022
Treatments Being Tested
Type 2 diabetes (T2D) could modulate CYP450 activities involved in drug-met...
Status
Completed
Location
Centre hospitalier de l'Université de Montréal (CHUM)
Start Date
2015-04
Trial ID
NCT02291666
Treatments Being Tested